CTI begins patient enrollment in
Selected Abstract
CTI begins patient enrollment in ISA247 Phase IIB clinical program on behalf of Isotechnika.(Clinical Trial and Consulting Services)(Instituto de Investigaciones Biomedicas)( prevention of organ graft rejection in patients undergoing kidney transplantation)(Brief Article)
CTI Clinical Trial and Consulting Services (CTI), Cincinnati, OH announced it has begun patient enrollment in a Phase IIB clinical program of ISA247 for the prevention of organ graft rejection in patients undergoing kidney transplantation. CTI is managing the clinical trial program on behalf of ... February 28, 2006; Transplant News
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
CTI begins patient enrollment in ISA247 Phase IIB clinical program on behalf of Isotechnika.(Clinical Trial and Consulting Services)(Instituto de Investigaciones Biomedicas)( prevention of organ graft rejection in patients undergoing kidney transplantation)(Brief Article)
|
